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Background
Plasmodium vivax uses duffy antigen to invade the human
erythrocytes but reports of duffy negative infection by
P. vivax indicate that this parasite may also be using some
other alternative receptors for the invasion [1]. Studies are
therefore required to identify these additional parasite
molecules which are involved in host-parasite interaction.
Plasmodium vivax, contains a family of tryptophan rich
antigens containing positionally conserved tryptophan
residues. These antigens can induced significant cellular
and humoral responses in human individuals [2,3] and few
showed interaction with erythrocytes.
Materials and methods
Recombinant Plasmodium vivax tryptophan-rich antigens
were purified by Ni-NTA affinity chromatography. Hepari-
nized blood was collected from healthy lab individuals to
obtain human erythrocytes for binding assays, and from
the microscopically confirmed P.vivax infected individuals
for patients’ sera. Rabbit antibodies against PvTRAgs used
here were raised in the lab. Erythrocyte binding assays
were performed by cell ELISA and Flow cytometry [2,4].
Results
PvTRAgs binds to the human erythrocytes in a concentra-
tion dependent manner and not to the human lympho-
cytes. The binding was specific as competition with
untagged proteins inhibits the erythrocyte binding to 50%
at equimolar concentration. Antibodies raised against rab-
bits and produced by infected patients inhibit the binding
of respective PvTRAg at different dilutions. PvTRAg38
and PvATRAg74 was sensitive to chymotrypsin only and
not to the trypsin and neuraminidase while all other
PvTRAgs were resistant to all these proteases.
Conclusions
Six out of fifteen PvTRAgs bind specifically to the human
erythrocytes and were inhibited by rabbit anti PvTRAgs
and also by the antibodies produced during natural course
of P. vivax infection. There may be more than one RBC
receptor for these six PvTRAgs where only PvTRAg38 and
PvATRAg74 are sensitive to chymorypsin while others
using those molecules which are other than glycophorin
and sialoglycoproteins. Studies are in progress to investi-
gate the respective RBC receptors for these PvTRAgs and
their role in erythrocyte invasion process.
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